{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:18:39Z","timestamp":1790605119553,"version":"4.1.0"},"reference-count":7,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1993,4]]},"abstract":"<jats:p>A 72 year old white man developed acute hepatic impairment and renal failure within 24 hours of starting intravenous amiodarone for paroxysmal ventricular tachycardia. After normal initial investigations, there was a noticeable rise in serum transaminases as well as an increase in clotting times, a decrease in renal function and a thrombocytopenia. These changes returned to normal within seven days of withdrawal of the drug without specific treatment, and the patient was later treated with oral amiodarone without any further evidence of hepatotoxicity. Intravenous amiodarone has been implicated in acute hepatic disease on four previous occasions, but it is suggested that polysorbate 80, an organic surfactant added to the intravenous infusion, is a more likely cause of this complication. Similar reactions have been described with polysorbate 80 in association with the 'E-ferol' syndrome in infants. The occurrence of acute hepatic impairment with intravenous amiodarone does not necessarily preclude the use of this drug by mouth.<\/jats:p>","DOI":"10.1136\/gut.34.4.565","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"565-566","source":"Crossref","is-referenced-by-count":59,"title":["Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?"],"prefix":"10.1136","volume":"34","author":[{"given":"A","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1993,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.CIR.67.1.45","article-title":"Side effects of long term amiodarone therapy","volume":"67","author":"Harris, L.; McKenna, W.; Rowland, E.; Storey, G.; Krikler, D.","year":"1983","unstructured":"Harris L, McKenna W, Rowland E, Storey G, Krikler D. Side effects of long term amiodarone therapy. Circulation 1983; 67: 45.","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.287.6386.175","article-title":"Adverse reactions during treatment with amiodarone hydrochloride","volume":"287","author":"McGovern, B.; Garan, H.; Kelly, E.; Ruskin, J.N.","year":"1983","unstructured":"McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. BMJ 1983; 287: 175-80.","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-2999(69)90049-1","article-title":"Longterm hepatic tolerance of amiodarone in the clinic","volume":"8","author":"Plonteux, G.; Heagham, C.; Ernowald, H.; Vandeghen, N.","year":"1969","unstructured":"Plonteux G, Heagham C, Ernowald H, Vandeghen N. Longterm hepatic tolerance of amiodarone in the clinic. Eur J Pharmacol 1969; 8: 369-76.","journal-title":"Eur J Pharmacol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/pgmj.65.767.707-a","article-title":"Acute hepatic dysfunction following parenteral amiodarone administration","volume":"65","author":"Stevenson, R.N.S.; Nayam, T.H.; Davies, JR","year":"1989","unstructured":"Stevenson RNS, Nayam TH, Davies JR. Acute hepatic dysfunction following parenteral amiodarone administration. PostgradMedJ 1989; 65: 707-8.","journal-title":"PostgradMedJ"},{"key":"ref_5","first-page":"225","article-title":"Probable early acute hepatitis with parenteral amiodarone","volume":"9","author":"Lupon-Roses, J.; Simo-Canonge, R.; Lu-Cortez, L.; PermanyerMiralda, G.; Allende-Mondus, H.","year":"1986","unstructured":"Lupon-Roses J, Simo-Canonge R, Lu-Cortez L, PermanyerMiralda G, Allende-Mondus H. Probable early acute hepatitis with parenteral amiodarone. Cltn Cardiol 1986; 9: 225-9.","journal-title":"Cltn Cardiol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/hrt.59.6.690","article-title":"Acute hepatitis after parenteral amiodarone administration","volume":"59","author":"Pye, M.; Northcote, R.J.; Cobbe, S.M.","year":"1988","unstructured":"Pye M, Northcote RJ, Cobbe SM. Acute hepatitis after parenteral amiodarone administration. Br Heart J 1988; 59: 690-1.","journal-title":"Br Heart J"},{"key":"ref_7","first-page":"329","article-title":"The E-Ferol syndrome solved? Side effects of drugs, Annual","volume":"1988","author":"Ruter, H.D.","year":"12.","unstructured":"Ruter HD. The E-Ferol syndrome solved? Side effects of drugs, Annual 12. 1988: 329."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.34.4.565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:45:46Z","timestamp":1765075546000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.34.4.565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1993,4,1]]},"published-print":{"date-parts":[[1993,4]]}},"alternative-id":["10.1136\/gut.34.4.565"],"URL":"https:\/\/doi.org\/10.1136\/gut.34.4.565","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}